Adial Pharmaceuticals
Sep 19, 2022
Adial’s Micro-formulation: Opening New Massive Alcohol Use Disorder Treatment Market Opportunities
Key Highlights Through the use of genetic screening, i.e., a companion genetic bio-marker intended to identify patients most likely to respond to therapy, AD04 humanizes the alcohol use disorder treatment, which could lead to an increase in the usage of AD04Without the need for abstinence, AD04’s novel mechanism...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
